Cladribine Treatment Outcomes in Hairy Cell Leukemia: A Single-center Experience

Aim: Hairy cell leukemia (HCL) is a rare, indolent, chronic B-cell lymphoproliferative disorder. This study aimed to assess the clinical features, treatment responses, and outcomes of patients with HCL monitored at our institution. Methods: We conducted a retrospective cohort study of 25 patients d...

Full description

Bibliographic Details

Main Authors:	Sema Seçilmiş, Burcu Aslan Candır, Samet Yaman, Ersin Bozan, Bahar Uncu Ulu, Tuğçe Nur Yiğenoğlu, Dicle İskender, Merih Kızıl Çakar
Format:	Artigo
Language:	Inglês
Published:	Ankara Hematology Oncology Association 2025-12-01
Series:	Acta Haematologica Oncologica Turcica
Subjects:	hairy cell leukaemia cladribine prognosis purine nucleoside analog
Online Access:	https://www.actaoncologicaturcica.com/articles/cladribine-treatment-outcomes-in-hairy-cell-leukemia-a-single-center-experience/doi/ahot.galenos.2025.2025-7-4
Tags:	Add Tag No Tags, Be the first to tag this record!